Michelle Doig has over 20 years’ experience working with life sciences companies at leading International Venture Capital and Investment Banking Firms.
She joined Omega Funds in December 2016, as a Partner and Head of Corporate Development. Prior to that, she was Director of Corporate Finance at Third Rock Ventures from 2013 to 2016, where she supported numerous portfolio companies. From 2004 to 2013, Ms. Doig was a Principal, Corporate Finance at Abingworth.
After graduating with honors from the Richard Ivey School of Business at Western University, London, Ontario, Michelle began her career as a life sciences investment banker with multiple investment firms, including Morgan Stanley (Toronto and New York), JPM H&Q (New York and San Francisco) and Lehman Brothers (London, UK).
Michelle served as a Director of the Nuvation Bio Inc. from July 2019 to June 2021 and is currently serving as a Director and President of Omega Alpha SPAC.